U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
INTERLEUKIN-12 HUMAN RECOMBINANT
02FXP10O2U
Investigational
General
Names
14
Classification
6
Identifiers
4
Subunits
2
Related Substances
1
INTERLEUKIN-12 HUMAN RECOMBINANT
02FXP10O2U
Investigational
General
Approval Year
Unknown
139,594
Names
14
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
INTERLEUKIN-12 HUMAN RECOMBINANT
Common Name
English
RECOMBINANT HUMAN NK CELL STIMULATORY FACTOR
Common Name
English
NMIL12
Code
English
RH-IL-12
Common Name
English
NMIL-12
Code
English
Showing 1 to 5 of 14 entries
Previous
1
2
3
Next
Classification
6
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of pancreatic cancer
FDA ORPHAN DRUG
663218
Positive
EU ORPHAN DRUG
Positive
Treatment of acute radiation syndrome
EU-Orphan Drug
EU/3/16/1727
Designated
ORPHAN DRUG
Designated
Treatment of acute radiation syndrome
FDA ORPHAN DRUG
531916
Designated
ORPHAN DRUG
Designated
Treatment of malignant glioma
FDA ORPHAN DRUG
552316
Designated
ORPHAN DRUG
Designated
Treatment of renal cell carcinoma.
FDA ORPHAN DRUG
107597
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Identifiers
4
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
RXCUI
1328172
PRIMARY
FDA UNII
02FXP10O2U
PRIMARY
NCI_THESAURUS
C90966
PRIMARY
DAILYMED
02FXP10O2U
PRIMARY
Showing 1 to 4 of 4 entries
Previous
1
Next
Subunits
2
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Related Substances
1
ACTIVE MOIETY
02FXP10O2U
INTERLEUKIN-12 HUMAN RECOMBINANT
